| Literature DB >> 35737068 |
Mariagioia Petraretti1, Antonietta Siciliano1, Federica Carraturo1, Alessio Cimmino2, Antonino De Natale1, Marco Guida1, Antonino Pollio1, Antonio Evidente2, Marco Masi2.
Abstract
Biocides based on chemical synthetic compounds have been commonly used to counteract damages caused by microorganisms on stone cultural heritage. However, in the last few years, the use of commercial and traditional biocides has been banned and/or limited due to their dangerous profile for the environment, as well as human and animal health. Natural products could be used as suitable alternatives for cultural heritage purposes, as they have low toxicity and stability compared with synthetic pesticides. Even if most of the investigated solutions have already shown promising results, their efficiency, ecotoxicological, and chemical features are poorly investigated. In this manuscript, we aimed to evaluate the ecotoxicological profile of four fungal metabolites-namely, cavoxin, epi-epoformin, seiridin, and sphaeropsidone-with potential antimicrobial properties for monumental artworks. A battery of ecotoxicological tests using Aliivibrio fischeri (bacterium), Raphidocelis subcapitata (alga), Raphanus sativus L. (macrophyte), Daphnia magna (crustacean), and Caenorhabditis elegans (nematode) revealed a relative lower toxicity of these compounds, especially when compared with Preventol® and Rocima®, commercial biocides mainly used for the conservation of cultural heritage.Entities:
Keywords: antifungal; biodeterioration; cavoxin; cultural heritage; epi-epoformin; fungi; natural compounds; seiridin; sphaeropsidone
Mesh:
Substances:
Year: 2022 PMID: 35737068 PMCID: PMC9227397 DOI: 10.3390/toxins14060407
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 5.075
Figure 1Chemical structures of compounds 1–4.
Analytical characteristics of calibration curves a and quantification of compounds 1–4 culture medium (ISO 2012) after 72 h.
| Compound | Rt (min) | R2 | Detection Limit (μg) | Compound Detected (μg) in 10 μL | % of Compound Present in the Culture Medium after 72 h |
|---|---|---|---|---|---|
| cavoxin ( | 4.790 | 0.9998 | 0.0001 | n.d. b | 0 |
| 1.830 | 0.9997 | 0.0001 | 0.00095 ± 0.0001 | 95 | |
| sphaeropsidone ( | 3.200 | 0.9998 | 0.0001 | 0.00092 ± 0.0002 | 92 |
| seiridin ( | 4.080 | 0.9996 | 0.0003 | 0.00090 ± 0.0003 | 90 |
a Calculated in the form y = a + bx, where y is the chromatographic peak area and x is the μg of compound with a number of data points = 21; b n.d. = not detected.
Figure 2Chromatographic profiles: (A) standard sample of cavoxin (1), 1 μg/mL at 286 nm; (B) standard sample of epi-epoformin (2), 1 μg/mL at 237 nm; (C) standard sample of sphaeropsidone (3), 1 μg/mL at 257 nm; (D) standard sample of seiridin (4), 1 μg/mL at 215 nm; (E) culture medium (ISO medium 2012) 72 h after the addition of cavoxin (1), 0.1 μg/mL at 286 nm; (F) culture medium (ISO medium 2012) 72 h after the addition of epi-epoformin (2), 0.1 μg/mL at 237 nm; (G) culture medium (ISO medium 2012) 72 h after the addition of sphaeropsidone (3), 0.1 μg/mL at 257 nm; (H) culture medium (ISO medium 2012) 72 h after the addition of seiridin (4), 0.1 μg/mL at 215 nm.
EC5, EC20, and EC50 values for cavoxin, epi-epoformin, seiridin, and sphaeropsidone after exposure to R. subcapitata, A. fischeri, D. magna, and C. elegans a.
| Organism | Compound | EC5 | EC20 | EC50 |
|---|---|---|---|---|
| cavoxin ( | 15.97 (10.11–25.13) | 20.93 (13.25–32.96) | 35.98 (22.77–56.67) | |
|
| 1.91 (1.28–2.99) | 2.58 (1.70–4.10) | 4.67 (2.98–7.70) | |
| sphaeropsidone ( | 1.78 (1.32–2.45) | 3.43 (2.49–4.82) | 12.78 (8.95–18.64) | |
| seiridin ( | n.d. | n.d. | n.d. | |
| cavoxin ( | 1.42 (0.93–2.24) | 2.59 (1.66–4.16) | 8.57 (5.24–14.42) | |
|
| 0.59 (0.33–1.15) | 1.20 (0.64–2.48) | 5.12 (2.50–11.58) | |
| sphaeropsidone ( | 4.12 (3.29–5.15) | 10.49 (8.38–13.14) | 68.14 (54.43–85.29) | |
| seiridin ( | 5.69 (2.95–11.00) | 10.01 (5.18–19.35) | 30.96 (16.02–59.84) | |
| cavoxin ( | 2.64 (0.22–1.37) | 4.36 (0.38–2.20) | 1.91 (1.11–5.66) | |
| 1.89 (1.13–3.36) | 2.68 (1.57–4.84) | 5.36 (3.03–10.04) | ||
|
| sphaeropsidone ( | 4.26 (1.20–5.06) | 6.49 (1.83–12.96) | 15.07 (4.26–16.34) |
| seiridin ( | n.d. | n.d. | n.d. | |
| cavoxin ( | 1.98 (1.08–3.91) | 3.34 (1.77–6.80) | 9.44 (4.73–20.52) | |
| 1.10 (0.63–2.05) | 1.56 (0.88–2.97) | 3.12 (1.70–6.19) | ||
|
| sphaeropsidone ( | 1.12 (0.58–2.54) | 2.05 (1.00–5.02) | 6.88 (2.97–19.69) |
| seiridin ( | n.d. | n.d. | n.d. |
a Values are in mg/L; n.d. = not determined; EC = effective concentration; average EC values are provided with ±95% confidence limit values in brackets (n = 3).